Evolution of Syncytium-inducing and Non-syncytium-inducing Biological Virus Clones in Relation to Replication Kinetics During the Course of Human Immunodeficiency Virus Type 1 Infection
Overview
Affiliations
To investigate the temporal relationship between human immunodeficiency virus type 1 (HIV-1) replicative capacity and syncytium-inducing (SI) phenotype, biological and genetic characteristics of longitudinally obtained virus clones from two HIV-1-infected individuals who developed SI variants were studied. In one individual, the emergence of rapidly replicating SI and non-syncytium-inducing (NSI) variants was accompanied by a loss of the slowly replicating NSI variants. In the other subject, NSI variants were always slowly replicating, while the coexisting SI variants showed an increase in the rate of replication. Irrespective their replicative capacity, the NSI variants remained present throughout the infection in both individuals. Phylogenetic analysis of the V3 region showed early branching of the SI variants from the NSI tree. Successful SI conversion seemed a unique event since no SI variants were found among later-stage NSI variants. This was also confirmed by the increasing evolutionary distance between the two subpopulations. At any time point during the course of the infection, the variation within the coexisting SI and NSI populations did not exceed 2%, indicating continuous competition within each viral subpopulation.
In-house ELISA protocols for capsid p24 detection of diverse HIV isolates.
Molina M, Vink M, Berkhout B, Herrera-Carrillo E Virol J. 2023; 20(1):269.
PMID: 37978551 PMC: 10656996. DOI: 10.1186/s12985-023-02242-5.
The -HIV syndemic interaction: why treating infection may be crucial for HIV-1 eradication.
Waters R, Ndengane M, Abrahams M, Diedrich C, Wilkinson R, Coussens A Future Virol. 2020; 15(2):101-125.
PMID: 32273900 PMC: 7132588. DOI: 10.2217/fvl-2019-0069.
Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.
Nankya I, Tebit D, Abraha A, Kyeyune F, Gibson R, Jegede O AIDS Res Ther. 2015; 12:34.
PMID: 26435727 PMC: 4592561. DOI: 10.1186/s12981-015-0066-7.
The impact of HIV-1 genetic diversity on the efficacy of a combinatorial RNAi-based gene therapy.
Herrera-Carrillo E, Berkhout B Gene Ther. 2015; 22(6):485-95.
PMID: 25716532 DOI: 10.1038/gt.2015.11.
Tomasini-Grotto R, Montes B, Triglia D, Torres-Braconi C, Aliano-Block J, Zanotto P Braz J Microbiol. 2013; 41(3):720-8.
PMID: 24031549 PMC: 3768648. DOI: 10.1590/S1517-83822010000300024.